GTC Biotherapeutics (fka GTCB)

[wjlknew]

>No––this is not the definition. Rather, the definition of a FoB is a biopharmaceutical whose regulatory approval relies, in whole or in part, on the clinical data of a similar drug.<

Now, there is a self-serving statement if I ever heard one. I would have thought the definition of a biosimilar would refer to the finished product, not to the process to arrive at the finished product.